Cigna Investments Inc Eli Lilly & CO Transaction History

Cigna Investments Inc

$573 Million
Q4 2024

A detailed history of Cigna Investments Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cigna Investments Inc holds 8,235 shares of LLY stock, worth $7.23 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

8,235

Previous 8,279 0.53%

Holding current value

$7.23 Million

Previous $7.33 Million 13.32%

% of portfolio

1.11%

Previous 1.29%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$727.2 - $932.06 $31,996 - $41,010	-44 Reduced 0.53%	8,235 $6.36 Million
Q3 2024 Oct 28, 2024	SELL	$772.14 - $960.02 $410,778 - $510,730	-532 Reduced 6.04%	8,279 $7.33 Million
Q2 2024 Jul 17, 2024	SELL	$724.87 - $909.04 $63,063 - $79,086	-87 Reduced 0.98%	8,811 $7.98 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $38,493 - $51,498	-65 Reduced 0.73%	8,898 $6.92 Million
Q4 2023 Jan 22, 2024	SELL	$525.19 - $619.13 $17,856 - $21,050	-34 Reduced 0.38%	8,963 $5.23 Million
Q3 2023 Oct 23, 2023	SELL	$434.7 - $599.3 $474,692 - $654,435	-1,092 Reduced 10.82%	8,997 $4.83 Million
Q2 2023 Aug 01, 2023	SELL	$350.74 - $468.98 $7,716 - $10,317	-22 Reduced 0.22%	10,089 $4.73 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $57,777 - $67,856	-186 Reduced 1.81%	10,111 $3.47 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $6,431 - $7,493	20 Added 0.19%	10,297 $3.77 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $131,340 - $149,676	-443 Reduced 4.13%	10,277 $3.32 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $1.06 Million - $1.25 Million	-3,813 Reduced 26.24%	10,720 $3.48 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $897,219 - $1.12 Million	-3,823 Reduced 20.83%	14,533 $4.16 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $1.44 Million - $1.79 Million	-6,412 Reduced 25.89%	18,356 $5.07 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $98,168 - $120,810	-443 Reduced 1.76%	24,768 $5.72 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $697,103 - $901,697	-3,861 Reduced 13.28%	25,211 $5.79 Million
Q1 2021 May 10, 2021	BUY	$164.32 - $212.72 $111,901 - $144,862	681 Added 2.4%	29,072 $5.43 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $217,085 - $287,256	1,664 Added 6.23%	28,391 $4.79 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $1.15 Million - $1.33 Million	-7,866 Reduced 22.74%	26,727 $3.96 Million
Q2 2020 Aug 17, 2020	BUY	$136.42 - $164.18 $426,721 - $513,555	3,128 Added 9.94%	34,593 $5.68 Million
Q1 2020 May 11, 2020	BUY	$119.05 - $147.35 $177,503 - $219,698	1,491 Added 4.97%	31,465 $4.37 Million
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $509,687 - $631,293	4,767 Added 18.91%	29,974 $4.19 Million
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $90,771 - $98,736	850 Added 3.49%	25,207 $2.87 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $99,821 - $116,517	-901 Reduced 3.57%	24,357 $2.65 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $523,157 - $615,794	-4,700 Reduced 15.69%	25,258 $3.28 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $207,458 - $232,415	1,959 Added 7.0%	29,958 $3.47 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $220,230 - $275,250	-2,565 Reduced 8.39%	27,999 $3.04 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $379,938 - $436,050	-5,019 Reduced 14.11%	30,564 $2.61 Million
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $20,110 - $23,739	-271 Reduced 0.76%	35,583 $2.75 Million
Q4 2017 Jan 26, 2018	SELL	$81.94 - $87.89 $123,073 - $132,010	-1,502 Reduced 4.02%	35,854 $3.03 Million
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $2.88 Million - $3.2 Million	37,356	37,356 $3.2 Million

Others Institutions Holding LLY

# of Institutions

4,121

Shares Held

740M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $835B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.

Account

Cigna Investments Inc Eli Lilly & CO Transaction History